News

Aestus is expected to develop the product as ATx08-001, a novel therapeutic for the treatment of neuropathic pain. The first clinical trial will start later this year. Aestus

Suzhou Erye pharma said that its new facility now has obtained government certification, is now fully operational and is manufacturing products on these two production lines. The new

Abbott had received independent 510(k) clearances for both the Abbott RealTime Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) assay and the Abbott m2000 System. They are required to be used together

OrSense said that the presentation provides data of NBM 200, a non-invasive Hb measurement system for various hematological applications including anemia monitoring, hemorrhage detection and pre-donation screening. Hb

As per the terms of the agreement MMV is expected to initially have access to AstraZeneca’s compound library. MMV is also expected to seek to identify compounds that

Forest Labs and Gedeon Richter have evaluated the investigational NR2B-selective NMDA (N-methyl D-aspartate) receptor antagonist, Radiprodil (RGH-896) in the clinical trial for the treatment of neuropathic pain associated

Dr Morich, after holding important roles in Bayer, is currently CEO of Noxxon Pharma, and also is one of the Takeda global advisory board members. As EVP of

Eloxatin is a registered trademark of sanofi aventis US. It is an antineoplastic that works by killing cancer cells and slowing tumor growth, is a cancer medication that

PSE stated that gPROMS is used by process industry companies in the pharmaceutical, oil and gas, chemicals and petrochemicals, power generation, clean energy, food & beverage, consumer products